Fuse Oncology, Inc. — Form D
Fuse Oncology, Inc. of GREENSBORO, NC, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-21. The offering totals $9.7M, of which $8.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-04-21
- Form: D
- Accession: 0001931320-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $9.7M
- Amount sold: $8.9M
- Remaining: $828K
- Investors: 20
- Date of first sale: 2023-04-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-479689
Issuer
- Name: Fuse Oncology, Inc.
- CIK: 0001931320
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 4214 WEST WENDOVER AVE., GREENSBORO, NC, 27407
- Phone: 828-719-8279
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| James Bauler | Director | Seneca, SC |
| Jay Brennan | Director | Greensboro, NC |
| John Miller | Director | West Jordan, UT |
| James Bauler | Executive Officer | Seneca, SC |
| Benjamin Sintay | Executive Officer | Greensboro, NC |
| John Strider | Executive Officer | Greensboro, NC |
| David Wiant | Executive Officer | Greensboro, NC |
| David Wiantt | Executive Officer | Greensboro, NC |
Other filings by this issuer (1)
More